Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer

被引：1
|
作者：
Morris, Patrick G. [1 ]
McArthur, Heather L. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10065 USA
来源：
ONCOLOGIST | 2012年 / 17卷 / 10期
关键词：
D O I：
10.1634/theoncologist.2012-0318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E33 / E33
页数：1
相关论文
共 50 条
  • [1] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer In Reply
    Connolly, Roisin M.
    Bardia, Aditya
    [J]. ONCOLOGIST, 2012, 17 (10): : E34 - E34
  • [2] Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    McArthur, Heather L.
    Mahoney, Kathleen M.
    Morris, Patrick G.
    Patil, Sujata
    Jacks, Lindsay M.
    Howard, Jane
    Norton, Larry
    Hudis, Clifford A.
    [J]. CANCER, 2011, 117 (24) : 5461 - 5468
  • [3] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    [J]. Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
  • [4] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
  • [5] Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    [J]. Breast Cancer Research and Treatment, 2016, 159 : 393 - 393
  • [6] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
    Tolaney, Sara M.
    Barry, William T.
    Dang, Chau T.
    Yardley, Denise A.
    Moy, Beverly
    Marcom, P. Kelly
    Albain, Kathy S.
    Rugo, Hope S.
    Ellis, Matthew
    Shapira, Iuliana
    Wolff, Antonio C.
    Carey, Lisa A.
    Overmoyer, Beth A.
    Partridge, Ann H.
    Guo, Hao
    Hudis, Clifford A.
    Krop, Ian E.
    Burstein, Harold J.
    Winer, Eric P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 134 - 141
  • [7] Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Cochereau, D.
    Cottu, P.
    [J]. ONCOLOGIE, 2015, 17 (04) : 194 - 196
  • [8] Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers.
    McArthur, H. L.
    Mahoney, K.
    Morris, P. G.
    Patil, S.
    Jacks, L. M.
    Howard, J.
    Norton, L.
    Hudis, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Impact of adjuvant trastuzumab (T) with chemotherapy on breast cancer specific and cardiac outcomes in older women with small, node-negative HER2-positive breast cancer
    Cadoo, K. A.
    Morris, P. G.
    Patil, S.
    Norton, L.
    Hudis, C. A.
    McArthur, H. L.
    [J]. CANCER RESEARCH, 2013, 73
  • [10] A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer
    Brooks, Gabriel
    Borges, Virginia
    Singh, Meenakshi
    Rabinovitch, Rachel
    Finlayson, Christina
    Elias, Anthony
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (11): : 1270 - 1276
12345